The independent source for health policy research, polling, and news.
20,981-21,000 of 113,118 results
Even some Democratic members have voiced opposition to House Speaker Nancy Pelosi's (D-Calif.) sweeping plan, but it is expected to pass the lower chamber on Friday. Republicans, who have been taking a wait-and-see approach to offering another round of emergency relief, widely panned the legislation.
Gilead has a reputation for placing astronomical prices on breakthrough drugs. But with the whole world's eyes on the drugmaker, what will it charge for remdesivir, the only drug that everyone wants right now? Stat talks to experts to get a sense of what to expect. In other pharmaceutical news: President Donald Trump wants essential drugs to be manufactured in U.S. instead of China; scientists eye a cocktail of medications to best treat COVID patients; and the search for an elusive cure has researchers thinking outside the box.
Fears that the United States will trample other countries to secure a vaccine prompted more than 140 world leaders to sign an open letter to all governments demanding that COVID-19 vaccines be considered a “global good” to be shared equitably. Meanwhile, President Donald Trump said he would mobilize the military to help distribute a vaccine once it's ready, with a focus on nursing homes and the elderly.
Reuters looks at where the development stands for apps meant to help public health officials track the virus. In other health tech news: policing misinformation, drone-based enforcement of social distancing and software that lets bosses watch their employees work.
The agency is launching an investigation into Abbott's 15-minute test, which has been touted and used by the White House. A preliminary study released this week found that it can miss nearly half of positive coronavirus cases.
Confusion abounds as Wisconsin bars, restaurants and other businesses as owners try to figure out the new rules after the state's Supreme Court overturned Gov. Tony Evers' stay-at-home order.
Wisconsin, Michigan and Pennsylvania are all electoral battleground states that voted for President Donald Trump in 2016 and will again be crucial in the 2020 presidential election. The fight over reopening in those particular states, which can swing both blue and red, is particularly heated because of those underlying politics. But leaders across the country are struggling to strike a balance as they start to lift restrictions.
The flow charts and check lists that are geared toward helping restaurants and business reopen focus mainly on basic tips like social distancing and hand washing.
Speaking in Allentown, Pa., at an Owens & Minor distribution center for medical supplies, President Donald Trump said he is "determined that America will be fully prepared for any of the future outbreaks, of which we hope there’s going to be none."
Dr. Rick Bright painted a grim, chaotic picture of the White House's COVID-19 response efforts for the House Energy and Commerce Subcommittee on Health, testifying that the U.S. still lacks a comprehensive plan for ensuring a supply of basic supplies like swabs needed to administer coronavirus tests. HHS Secretary Alex Azar dismissed Bright's testimony. “This is like someone who was in choir trying to say he was a soloist back then,” Azar said. “His allegations do not hold water."
Because of the short supply, body bags are sometimes reused two or three times. Meanwhile, the global death toll surpasses a staggering 300,000 people.
Editorial writers weigh in on these pandemic topics and others.
Today's early morning highlights from the major news organizations.
California officials are calling on people to reach out if they've been targeted because it might help solve or prevent crimes in the future. Meanwhile, arrests and charges have been made in New York and Texas. Public health news is on backaches from working at home, the lack of memorials to the 1918 flu pandemic, the case for reopening schools, flying etiquette, the upcoming, regular flu season, unending gunshot emergencies, children's safety at home, challenges for people needing kidney dialysis, and a Black college's study on the higher number of Black Americans dying of COVID.
“When individuals paying to fund research leading to a therapy are also the first to receive it, there are concerns,” said Brian Fiske, vice president for research at the Michael J. Fox Foundation. Public health news is on lymphoma, lung and cancer treatments, promises from good bacteria and $15M penalty for CVS for not tracking opioids, as well.
Media outlets look at the developments that are occurring every day as scientists try to better understand the virus.
Without ever having the symptoms, cats can spread the virus to other cats, according to a study in the New England Journal of Medicine that concludes more research is needed to see if they could also infect the household.
The treatment has long been used internationally to treat dengue fever, cancer and hepatitis B and C. Studies during the SARS epidemic in 2003 suggested interferons might also be useful against coronaviruses. In other pharma news: patents, global remdesivir use, and hope from doctors.
After two years in the role, Atal Gawande says his time is better spent now in an advisory position for the health care venture. He also just published an article in the New Yorker about how to safely reopen the country.
Insurers no longer view the Affordable Care Act marketplace as a black hole for profits, but rather as a boon to their bottom line -- especially in the midst of a pandemic.
© 2026 KFF